These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38435190)

  • 1. Etiology of Drug-Induced Edema: A Review of Dihydropyridine, Thiazolidinedione, and Other Medications Causing Edema.
    Sinnathamby ES; Urban BT; Clark RA; Roberts LT; De Witt AJ; Wenger DM; Mouhaffel A; Willett O; Ahmadzadeh S; Shekoohi S; Kaye AD; Varrassi G
    Cureus; 2024 Feb; 16(2):e53400. PubMed ID: 38435190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and vascular mechanisms of thiazolidinedione-induced fluid retention.
    Yang T; Soodvilai S
    PPAR Res; 2008; 2008():943614. PubMed ID: 18784848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
    Sotiropoulos KB; Clermont A; Yasuda Y; Rask-Madsen C; Mastumoto M; Takahashi J; Della Vecchia K; Kondo T; Aiello LP; King GL
    FASEB J; 2006 Jun; 20(8):1203-5. PubMed ID: 16672634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?
    Goltsman I; Khoury EE; Winaver J; Abassi Z
    Pharmacol Ther; 2016 Dec; 168():75-97. PubMed ID: 27598860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes.
    Kotake D; Hirasawa N
    Eur J Pharmacol; 2013 May; 707(1-3):95-103. PubMed ID: 23542713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention.
    Horita S; Nakamura M; Satoh N; Suzuki M; Seki G
    PPAR Res; 2015; 2015():646423. PubMed ID: 26074951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.
    Susilawati E; Levita J; Susilawati Y; Sumiwi SA
    Med Sci (Basel); 2023 Aug; 11(3):. PubMed ID: 37606429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic macular edema.
    Stefánsson E
    Saudi J Ophthalmol; 2009 Jul; 23(2):143-8. PubMed ID: 23960851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications.
    Mudaliar S; Chang AR; Henry RR
    Endocr Pract; 2003; 9(5):406-16. PubMed ID: 14583425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies.
    Karalliedde J; Buckingham RE
    Drug Saf; 2007; 30(9):741-53. PubMed ID: 17722967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone increases endothelial cell migration and vascular permeability through Akt phosphorylation.
    Ku YH; Cho BJ; Kim MJ; Lim S; Park YJ; Jang HC; Choi SH
    BMC Pharmacol Toxicol; 2017 Aug; 18(1):62. PubMed ID: 28854981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory edema: a common side effect of antihypertensive therapy.
    Messerli FH
    Curr Cardiol Rep; 2002 Nov; 4(6):479-82. PubMed ID: 12379167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat.
    Ochodnicky P; Mesarosova L; Cernecka H; Klimas J; Krenek P; Goris M; van Dokkum RP; Henning RH; Kyselovic J
    Eur J Pharmacol; 2014 May; 730():51-60. PubMed ID: 24582928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edema from Taking Cinnamon for Treatment of Diabetes: Similar Biochemistry and Pathophysiology to Thiazolidinedione Medications.
    Crawford P; Crawford AJ
    J Am Board Fam Med; 2018; 31(5):809-811. PubMed ID: 30201678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular angiotensin-converting enzyme by telmisartan via the peroxisome proliferator-activated receptor gamma agonistic property in rats.
    Takai S; Jin D; Kimura M; Kirimura K; Sakonjo H; Tanaka K; Miyazaki M
    Hypertens Res; 2007 Dec; 30(12):1231-7. PubMed ID: 18344629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists.
    Weir MR; Rosenberger C; Fink JC
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):963-8. PubMed ID: 11587165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE Inhibitor-Induced Angioedema: a Review.
    Kostis WJ; Shetty M; Chowdhury YS; Kostis JB
    Curr Hypertens Rep; 2018 Jun; 20(7):55. PubMed ID: 29884969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
    Ko KD; Kim KK; Lee KR
    J Obes Metab Syndr; 2017 Jun; 26(2):102-106. PubMed ID: 31089503
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.